<?xml version="1.0" encoding="UTF-8"?>
<p>The ability of making antibodies, also exploiting cross-reactive memory responses, could be a double-edged sword. Cross-reactive antibodies are not always beneficial, and in some cases they can do harm by enhancing inflammatory immune responses and viral entry into cells [
 <xref rid="B113-vaccines-08-00224" ref-type="bibr">113</xref>,
 <xref rid="B114-vaccines-08-00224" ref-type="bibr">114</xref>]. However, even antibodies mediating viral infection can be protective in certain circumstances [
 <xref rid="B115-vaccines-08-00224" ref-type="bibr">115</xref>]. Even if the production of antibodies undergoes significant changes with ageing, there is not any proof that these changes are related to the higher severity of Covid-19 in the elderly.
</p>
